Nebenwirkungen · RotaTeq
RotaTeq oral solution Rotavirus vaccine (live) · Abschnitt 4.8 · PDF-Seite 7
HOS-208609 · Präparat HOS-154137
Intussusception Data from observational safety studies performed in several countries indicate that rotavirus vaccines carry an increased risk of intussusception, with up to 6 additional cases per 100,000 infants within 7 days of vaccination. There is limited evidence of a smaller increased risk following the second dose. The background incidence of intussusception in infants less than one year of age in these countries ranged from 25 to 101 per 100,000 infants per year. It remains unclear whether rotavirus vaccines affect the overall incidence of intussusception based on longer periods of follow up (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-18T17:41:00Z · SHA-256 1bf679a506a5932e9a995a26e74853821492506bfaf86c692c3c8611fb958c00 · Passage 12a9ae8a80c567a54c9f6edef76b61d10a610c27b921e4f318b845c7ee2032da · Zeichen 3944–4569 im Abschnitt